HUNTINGTON NATIONAL BANK - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 24 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2018$0
-100.0%
5190.0%0.00%
Q3 2018$1,0005190.0%0.00%
Q2 2018$05190.0%0.00%
Q1 2018$05190.0%0.00%
Q4 2017$0
-100.0%
5190.0%0.00%
Q3 2017$1,0005190.0%0.00%
Q2 2017$0
-100.0%
5190.0%0.00%
Q1 2017$2,0000.0%5190.0%0.00%
Q4 2016$2,000
-33.3%
5190.0%0.00%
Q3 2016$3,0000.0%5190.0%0.00%
Q2 2016$3,000
+50.0%
5190.0%0.00%
Q4 2015$2,0005190.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2016
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 545,000$122,0000.10%
Virtu Financial LLC 236,182$53,0000.00%
Planning Solutions Group LLC 14,293$3,0000.00%
Cutter & CO Brokerage, Inc. 10,000$2,0000.00%
Blume Capital Management, Inc. 2,546$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 17,483$4,0000.00%
Wealthspire Advisors, L.P. 8,235$2,0000.00%
Advisor Group, Inc. 2,100$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 2,250$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders